RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lack of communicationsHi Jkj.
Yes, there are all of these very positive things like new offices, Dr Peter Johann's positive announcement re rvx-208 and the more positive statement from the CC that signal this comapny is in business for the long term.
Don obviously has the support of the board but this may not mean much if Eastern doesn't have a seat. However, it's seems like KD is in support of him and that reassures me. At least he hasn't moved in in a hostile way. NGN Capital is on the board. So there is pretty good company and expertise.
Somebody has to fund the trial. KD apparently has not stepped up to the plate. AZ needs something like rvx-208 in a very,very big way and it would be a huge victory for them or Phfizer, IMO. If AZ stepped in with a CVR then KD would benefit almost immediately and I don't think he would allow the initial payment to be low. He would at least want to break even. Then he can kick back at a break even investment and make millions on the on each of the hurdle point payouts.
Also, he still has all of his Zenith shares and we all know how hot epigenitics is these days.
As much as I'm frustrated by the lack of communication, and am waivering, I'm still holding my postion on the basis that they can't communicate because they are deal making.
Cheers
Toinv